Jazz Pharmaceuticals Plc (JAZZ)
235.67
+2.66
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
235.53
-0.14
(-0.06%)
After-Hours: 20:00
Jazz Pharmaceuticals Shareholders Equity (Quarterly) : 4.802B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.802B |
| March 31, 2026 | 4.532B |
| December 31, 2025 | 4.319B |
| September 30, 2025 | 3.959B |
| June 30, 2025 | 3.706B |
| March 31, 2025 | 4.175B |
| December 31, 2024 | 4.094B |
| September 30, 2024 | 4.171B |
| June 30, 2024 | 3.763B |
| March 31, 2024 | 3.696B |
| December 31, 2023 | 3.737B |
| September 30, 2023 | 3.489B |
| June 30, 2023 | 3.526B |
| March 31, 2023 | 3.335B |
| December 31, 2022 | 3.086B |
| September 30, 2022 | 2.745B |
| June 30, 2022 | 3.201B |
| March 31, 2022 | 3.608B |
| December 31, 2021 | 3.965B |
| September 30, 2021 | 3.938B |
| June 30, 2021 | 4.131B |
| March 31, 2021 | 3.798B |
| December 31, 2020 | 3.660B |
| September 30, 2020 | 3.377B |
| June 30, 2020 | 3.142B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.808B |
| December 31, 2019 | 3.111B |
| September 30, 2019 | 3.054B |
| June 30, 2019 | 2.983B |
| March 31, 2019 | 2.730B |
| December 31, 2018 | 2.757B |
| September 30, 2018 | 3.027B |
| June 30, 2018 | 2.870B |
| March 31, 2018 | 2.787B |
| December 31, 2017 | 2.713B |
| September 30, 2017 | 2.469B |
| June 30, 2017 | 2.201B |
| March 31, 2017 | 1.984B |
| December 31, 2016 | 1.877B |
| September 30, 2016 | 1.716B |
| June 30, 2016 | 1.692B |
| March 31, 2016 | 1.607B |
| December 31, 2015 | 1.599B |
| September 30, 2015 | 1.563B |
| June 30, 2015 | 1.447B |
| March 31, 2015 | 1.305B |
| December 31, 2014 | 1.371B |
| September 30, 2014 | 1.341B |
| June 30, 2014 | 1.280B |
| March 31, 2014 | 1.249B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 98.22M |
| GH Research Plc | 359.49M |
| Cosmo NV | -- |
| Axsome Therapeutics, Inc. | 83.30M |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.08B |
| Total Liabilities (Quarterly) | 6.279B |
| Debt to Equity Ratio | 0.9183 |
| Current Ratio | 1.779 |
| Net Debt Paydown Yield | 1.29% |